Bulletin
Investor Alert

New York Markets Open in:

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 24, 2022, 6:12 p.m.

/zigman2/quotes/206690250/composite

$

88.93

Change

+0.90 +1.02%

Volume

Volume 193,421

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 87.38

$ 88.03

Change

+0.65 +0.74%

Day low

Day high

$87.12

$89.45

Open

52 week low

52 week high

$82.51

$120.54

Open

Andy Pasternak

Andy Pasternak is Chief Strategy Officer & Executive Vice President at Horizon Therapeutics Plc.

In the past he occupied the position of Partner at Bain & Co., Inc. and Partner at Oliver Wyman, Inc.

Mr. Pasternak received an MBA from The University of Chicago and an undergraduate degree from Northwestern University.

Transactions

Date Shares Transaction Value
02/18/2022 1,313   Disposition at $94.82 per share. 124,499
01/06/2022 349   Disposition at $100.23 per share. 34,981
01/06/2022 6,438   Disposition at $99.85 per share. 642,835
01/06/2022 700   Disposition at $98.33 per share. 68,831
01/06/2022 500   Disposition at $97.3 per share. 48,650
01/05/2022 21,710   Derivative/Non-derivative trans. at $101.84 per share. 2,210,947
01/05/2022 48,839   Derivative/Non-derivative trans. at $0 per share. 0
12/07/2021 1,525   Disposition at $100 per share. 152,500
11/04/2021 7,264   Disposition at $115.51 per share. 839,065
11/04/2021 2,728   Disposition at $114.49 per share. 312,329
11/04/2021 5,650   Disposition at $113.54 per share. 641,501
11/04/2021 2,706   Disposition at $112.44 per share. 304,263
11/04/2021 6,336   Disposition at $111.47 per share. 706,274
11/04/2021 5,484   Disposition at $110.64 per share. 606,750
11/04/2021 23,251   Derivative/Non-derivative trans. at $29.52 per share. 686,369
11/01/2021 5,503   Derivative/Non-derivative trans. at $118.29 per share. 650,950
11/01/2021 12,421   Derivative/Non-derivative trans. at $0 per share. 0
09/09/2021 496   Disposition at $108.26 per share. 53,697
09/09/2021 22,754   Disposition at $107.83 per share. 2,453,564
09/09/2021 23,250   Derivative/Non-derivative trans. at $29.52 per share. 686,340
07/28/2021 3,858   Derivative/Non-derivative trans. at $102.5 per share. 395,445
07/28/2021 8,708   Award at $0 per share. 0
02/17/2021 1,045   Derivative/Non-derivative trans. at $87.17 per share. 91,093
02/17/2021 2,358   Award at $0 per share. 0
01/05/2021 6,526   Derivative/Non-derivative trans. at $73.28 per share. 478,226
01/05/2021 14,513   Derivative/Non-derivative trans. at $0 per share. 0
11/01/2020 5,503   Derivative/Non-derivative trans. at $74.93 per share. 412,340
11/01/2020 12,420   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.